The study, published Oct. 9 in Arteriosclerosis, Thrombosis, and Vascular Biology, evaluated more than 10,000 COVID-19 infections between Feb. 1, 2020 and Dec. 31, 2020. The disease is associated with myocardial infarction and other major adverse cardiac events, but the study is among the first to explore the duration and determinants of these health risks.
Among the 2,868 hospitalized patients in this population, those infected with COVID-19 have a risk of heart attack, stroke, and death four times greater than that of those who were not infected.
The researchers, who work at California medical schools and Cleveland Clinic, also found these risks are long-lasting after a COVID-19 infection, which is different from other diseases.
Access the study here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
